Development and validation of a prognostic nomogram incorporating neutrophil-to-albumin ratio for predicting overall survival in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy
The NAR, an emergent biomarker combining nutritional and inflammatory status, offers a practical, low-cost, and non-invasive prognostic measure for NPC patients treated with CCRT. Additionally, the prognostic nomogram derived from NAR surpasses traditional staging systems in predictive accuracy.
Authors
- Si‐Fen Wang
- Xin Huang (ORCID: https://orcid.org/0000-0002-0359-7290)
- Weiqiong Ni
- Meng-Di Wang
- Zhi‐Qing Long (ORCID: https://orcid.org/0000-0003-0704-7947)
- Fangfang Duan (ORCID: https://orcid.org/0000-0002-7887-5232)
- Chao Zhang (ORCID: https://orcid.org/0000-0001-6418-8370)
- Wen Xia
- Jiayi Chen (ORCID: https://orcid.org/0000-0001-6417-290X)
- Xin Hua (ORCID: https://orcid.org/0000-0002-2045-1293)
- Fei Xu
- Gao Yun-sheng
Institutions
- Sun Yat-sen University (CN)
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e40881
- Citations
- 5
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.41
Funders
- Fundamental Research Funds for the Central Universities